Merck discontinues Phase 3 KeyVibe-010 trial of coformulation of Vibostolimab and Pembrolizumab
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
This acquisition enables MTD to open new, strategic markets
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Subscribe To Our Newsletter & Stay Updated